Epinephrine Pediatric Dose — Acute Allergic Reaction
Epinephrine is a catecholamine that acts on alpha- and beta-adrenergic receptors to produce vasoconstriction, bronchodilation, and stabilization of mast cell membranes. It is the first-line pharmacologic treatment for anaphylaxis and severe acute allergic reactions in pediatric patients. Prompt administration is critical to reversing the life-threatening hemodynamic and respiratory manifestations of anaphylaxis.
Pediatric Dosing
Administer epinephrine 1:1,000 concentration via intramuscular injection at a dose of 0.01 mg/kg/dose IM. The maximum single dose is 0.5 mg.
- Concentration: 1:1,000 (1 mg/mL)
- Dose: 0.01 mg/kg IM per dose
- Maximum single dose: 0.5 mg
Worked example: For a 20 kg child: 20 × 0.01 mg/kg = 0.2 mg IM (0.2 mL of 1:1,000 solution). For a 60 kg adolescent, the dose would be capped at 0.5 mg IM regardless of calculated weight-based dose. Repeat dosing may be considered if symptoms persist; consult institutional protocol for repeat dosing intervals.
Indications and Clinical Context
Epinephrine IM is indicated for anaphylaxis and severe acute allergic reactions in pediatric patients, including those presenting with urticaria accompanied by respiratory compromise, hypotension, or angioedema with airway involvement. Per PALS and international anaphylaxis guidelines, epinephrine is the cornerstone of initial management and should not be delayed in favor of antihistamines or corticosteroids, which are considered adjunctive therapies only.
Early recognition of anaphylaxis — particularly in children who may present atypically with isolated gastrointestinal symptoms or cardiovascular collapse — is essential to ensure timely epinephrine administration. Common triggers include foods (especially peanuts, tree nuts, and milk), insect stings, latex, and medications.
Administration and Monitoring
The preferred injection site is the anterolateral thigh (vastus lateralis), which provides more rapid and reliable absorption compared to the deltoid. Use the 1:1,000 concentration (1 mg/mL) for IM dosing; do not confuse with the 1:10,000 concentration used for IV resuscitation. Aspirate is not required prior to injection.
- Route: Intramuscular (anterolateral thigh preferred)
- Concentration: 1:1,000 only for this indication
- Max dose: 0.5 mg per dose
- Monitor for: Tachycardia, pallor, hypertension, anxiety, and arrhythmias following administration
- Positioning: Keep patient supine with legs elevated unless respiratory distress necessitates upright positioning
- Observation: Patients should be observed for a minimum biphasic reaction period per institutional protocol after epinephrine administration
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.